PMC:7358770 / 34026-34215
Annnotations
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T506","span":{"begin":2,"end":13},"obj":"Chemical"},{"id":"T507","span":{"begin":17,"end":30},"obj":"Chemical"},{"id":"T508","span":{"begin":112,"end":119},"obj":"Chemical"}],"attributes":[{"id":"A506","pred":"chebi_id","subj":"T506","obj":"http://purl.obolibrary.org/obo/CHEBI_33232"},{"id":"A507","pred":"chebi_id","subj":"T507","obj":"http://purl.obolibrary.org/obo/CHEBI_50803"},{"id":"A508","pred":"chebi_id","subj":"T508","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"}],"text":"e application of nanoparticles in vaccine formulations can not only improve the immunogenicity and stability of antigen, but also achieve targeted delivery and sustained release [126]. Nano"}
2_test
{"project":"2_test","denotations":[{"id":"32679328-31647394-48281347","span":{"begin":179,"end":182},"obj":"31647394"},{"id":"T91461","span":{"begin":179,"end":182},"obj":"31647394"}],"text":"e application of nanoparticles in vaccine formulations can not only improve the immunogenicity and stability of antigen, but also achieve targeted delivery and sustained release [126]. Nano"}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T965","span":{"begin":17,"end":30},"obj":"GO:0031982"},{"id":"T966","span":{"begin":80,"end":94},"obj":"BV_15"},{"id":"T967","span":{"begin":112,"end":119},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T83905","span":{"begin":14,"end":20},"obj":"CHEBI:16261;CHEBI:16261"},{"id":"T60667","span":{"begin":57,"end":60},"obj":"NCBITaxon:7460"},{"id":"T82055","span":{"begin":108,"end":114},"obj":"UBERON:0000912"}],"text":"e application of nanoparticles in vaccine formulations can not only improve the immunogenicity and stability of antigen, but also achieve targeted delivery and sustained release [126]. Nano"}